4[6]ATS.Hospital-acquired pneumonia in adults:Diagnosis assessment of severity,initial ant microbial therapy and preventative strategies.A consensus statement.Am j Respir crit care med,1996,153:1711-1725
5[7]Dubar LM,Wunderink RG,Habio MP,et al.High-dose,shortcourse levofloxacin for community acquired pneumonia:a-new treatment paradigm clin infect Dis,2003,37:752-760
6[8]Wilson L,Allegra L,Huchon G,et al.Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.chest,2004,125:953-964
7[9]Chastre J,Wolff,Fagon JY,et al,Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adult:a randomized trial.IAMA,2003,290:2588-2598
8[10]American Thoracic Society,Infectious Diseases Society.Guidelines for the management of adalt with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia.Am J Respir Crit Care Med,2005,171:388-416
3Craig WA. Pharmacokinetic/Pharmacyodynamic parameters:rationale for antibacterial dosing of mice and men[J]. Clin Infect Dis, 1998,26:1-10.
4Zhanel GG. Influence of pharmacyokinetic and pharmacodynamic Principles on Antibiotic Selection[J]. Curr Infect Dis Rep, 2001,3: 29-34.
5Tulkens PM. New strategies to avoid development of microbial resistance[C]. A symposium on resistance and the use and misuse of antimicrobial therapy, 2000,44-52.
6Maglio D, Nightingale CH, Nicolau DP. Extended interval aminoglycoside dosing : from concept to clinic[J]. Int J Antimicrob Agents, 2002,19 : 341-348.
7Prins JM, Speelman P. Once daily aminoglycosides: practical guideline[J]. Neth J Med, 1998,52 : 1-9.
8Hierholzer WJ,Garner JS, Adams AB, et al. Recommendations for preventing the spread of vancomycin resistance:Recommendations of the HICPAC[J]. Am J Infect Control, 1995,23: 87-94.
9HICPAC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin[J]. Morb Mortal Wkly Rep,2002,51:565-567.
10Schaad UB,Abdus Salam M,Aujard Y,et al. Use of fluoroquinolones in pediatrics : Consensus report of an International Society of Chemotherapy commission[J]. Pediatr Infect Dis J, 1995,14:1-9.
